BIO.B (Bio-Rad Laboratories) Marketable Securities : $1,212 Mil (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bio-Rad Laboratories's Marketable Securities for the quarter that ended in Sep. 2024 was $1,212 Mil.

Bio-Rad Laboratories's annual Marketable Securities increased from Dec. 2021 ($399 Mil) to Dec. 2022 ($1,356 Mil) but then declined from Dec. 2022 ($1,356 Mil) to Dec. 2023 ($1,203 Mil).

Bio-Rad Laboratories Marketable Securities Historical Data

The historical data trend for Bio-Rad Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Marketable Securities Chart

Bio-Rad Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

453.97

328.91

399.14

1,356.46

1,203.33

Bio-Rad Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															1,301.14	1,203.33	1,212.39	1,209.19	1,212.08

Bio-Rad Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Bio-Rad Laboratories (NYSE:BIO.B) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Bio-Rad Laboratories Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

BIO:USA

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.